Author: CCH Incorporated
Publisher: Wolters Kluwer
ISBN: 9780808011293
Category : Business & Economics
Languages : en
Pages : 642
Book Description
Medicare Prescription Drug, Improvement, and Modernization Act of 2003
Medicare Prescription Drug, Improvement, and Modernization Act of 2003
Author: United States. Congress
Publisher:
ISBN:
Category : Electronic government information
Languages : en
Pages : 850
Book Description
Publisher:
ISBN:
Category : Electronic government information
Languages : en
Pages : 850
Book Description
Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (H.R. 1).
Author: CCH Incorporated
Publisher:
ISBN:
Category : Medicare
Languages : en
Pages : 681
Book Description
Publisher:
ISBN:
Category : Medicare
Languages : en
Pages : 681
Book Description
Medicare Prescription Drug, Improvement, and Modernization Act of 2003
Author: United States. Congress
Publisher:
ISBN: 9780160679766
Category : Medical care, Cost of
Languages : en
Pages : 850
Book Description
Publisher:
ISBN: 9780160679766
Category : Medical care, Cost of
Languages : en
Pages : 850
Book Description
Medicare Prescription Drug and Modernization Act of 2003
Author: United States. Congress. House. Committee on Energy and Commerce
Publisher:
ISBN:
Category : Medicare
Languages : en
Pages : 256
Book Description
Publisher:
ISBN:
Category : Medicare
Languages : en
Pages : 256
Book Description
Adding a Prescription Drug Benefit to Medicare
Author: Carla D. Jones
Publisher:
ISBN: 9781423519461
Category :
Languages : en
Pages : 131
Book Description
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 added an outpatient prescription drug benefit to Medicare. This benefit had been a recurring topic among lawmakers, attempted many times since Medicare was enacted in 1965. The 2003 legislation marked the most significant and expensive overhaul of Medicare since its creation. It occurred at a time of record federal budget deficits and Republican control of Congress and the White House. The major compromise that allowed this legislation to succeed concerned the total funding to be made available, the amount of privatization in the design and administration of the benefit, and the scope of the coverage. This thesis identifies and describes the primary stakeholders involved and their influences on the benefit, including political parties, Congress, the Bush Administration and interest groups, and summarizes previous attempts at similar legislation. Sources include congressional testimony, government cost estimates, legislation, journal articles, and think-tanks. The thesis analyzes the legislative process that produced the Medicare reform and identifies problems and issues resulting from it.
Publisher:
ISBN: 9781423519461
Category :
Languages : en
Pages : 131
Book Description
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 added an outpatient prescription drug benefit to Medicare. This benefit had been a recurring topic among lawmakers, attempted many times since Medicare was enacted in 1965. The 2003 legislation marked the most significant and expensive overhaul of Medicare since its creation. It occurred at a time of record federal budget deficits and Republican control of Congress and the White House. The major compromise that allowed this legislation to succeed concerned the total funding to be made available, the amount of privatization in the design and administration of the benefit, and the scope of the coverage. This thesis identifies and describes the primary stakeholders involved and their influences on the benefit, including political parties, Congress, the Bush Administration and interest groups, and summarizes previous attempts at similar legislation. Sources include congressional testimony, government cost estimates, legislation, journal articles, and think-tanks. The thesis analyzes the legislative process that produced the Medicare reform and identifies problems and issues resulting from it.
Rare Diseases and Orphan Products
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309158060
Category : Medical
Languages : en
Pages : 442
Book Description
Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.
Publisher: National Academies Press
ISBN: 0309158060
Category : Medical
Languages : en
Pages : 442
Book Description
Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.
H.R. 1, Medicare Prescription Drug and Modernization Act of 2003
Author: United States. Congress. House. Committee on Rules
Publisher:
ISBN:
Category : Bills, Legislative
Languages : en
Pages : 136
Book Description
Publisher:
ISBN:
Category : Bills, Legislative
Languages : en
Pages : 136
Book Description
Competition and the Cost of Medicare's Prescription Drug Program
Author: Anna Cook
Publisher:
ISBN: 9781457856631
Category :
Languages : en
Pages : 48
Book Description
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (the Medicare Modernization Act, or MMA) substantially expanded the federal Medicare program by creating the prescription drug benefit known as Part D. In FY 2013, Medicare Part D covered 39 million people. The federal government spent $59 billion net of premiums on Part D in that year; after accounting for certain payments from states under the program, the net federal cost was $50 billion, which represented 10% of net federal spending for Medicare. A combination of broader trends in the prescription drug market and lower-than-expected enrollment in Part D has contributed to much lower spending for the program than projected when the MMA became law in 2003. This report examines the federal budgetary cost and competitive design of Medicare Part D and compares Medicare Part D and Medicaid Fee for Service. Figures and tables. This is a print on demand report.
Publisher:
ISBN: 9781457856631
Category :
Languages : en
Pages : 48
Book Description
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (the Medicare Modernization Act, or MMA) substantially expanded the federal Medicare program by creating the prescription drug benefit known as Part D. In FY 2013, Medicare Part D covered 39 million people. The federal government spent $59 billion net of premiums on Part D in that year; after accounting for certain payments from states under the program, the net federal cost was $50 billion, which represented 10% of net federal spending for Medicare. A combination of broader trends in the prescription drug market and lower-than-expected enrollment in Part D has contributed to much lower spending for the program than projected when the MMA became law in 2003. This report examines the federal budgetary cost and competitive design of Medicare Part D and compares Medicare Part D and Medicaid Fee for Service. Figures and tables. This is a print on demand report.
Waiving Points of Order Against the Conference Report to Accompany H.R. 1, Medicare Prescription Drug, Improvement, And Modernization Act of 2003
Author: United States. Congress. House. Committee on Rules
Publisher:
ISBN:
Category : Medicare
Languages : en
Pages : 2
Book Description
Publisher:
ISBN:
Category : Medicare
Languages : en
Pages : 2
Book Description